Notice Information
Notice Title
PROVISIONS OF PCR MASTER MIXES - CLONALITY TESTING
Notice Description
The All Wales Medical Genomics Service (AWMGS) is awarding a direct contract for the supply of PCR mastermixes and associated reagents required for B and T cell clonality testing. These assays are critical for diagnosing and monitoring haematological malignancies such as lymphoma and must include validated clonal and polyclonal controls, as well as a control gene, to ensure accurate and reproducible results. In addition to product supply, the contract includes technical support to maintain continuity of service. Changing supplier would require extensive revalidation and re-accreditation of all assays, which would be a major undertaking and cause significant disruption to diagnostic services. This would lead to delays in patient testing, risking late or missed diagnoses and potentially endangering patient health and outcomes. The direct award is therefore essential to safeguard patient safety, maintain compliance with UKAS standards, and ensure uninterrupted delivery of critical genomic testing services across Wales
Procurement Information
The All Wales Medical Genomics Service (AWMGS) requires PCR mastermixes and associated reagents for B and T cell clonality testing, which are critical for diagnosing and monitoring haematological malignancies such as lymphoma. These assays must include validated clonal and polyclonal controls and a control gene to ensure accurate and reproducible results. Changing supplier would necessitate full revalidation and re-accreditation of all existing assays under UKAS ISO 15189:2022 standards--a process that is highly complex, resource-intensive, and time-consuming. This would cause significant disruption to diagnostic services, resulting in delays to patient testing and reporting. Such delays pose a serious risk to patient safety, as timely diagnosis is essential for initiating treatment and improving clinical outcomes. Any interruption could lead to missed or late diagnoses, directly endangering patient health and potentially impacting survival rates. To avoid these unacceptable risks and maintain continuity of service, a direct award is the only viable option, service resilience, and safeguarding patient care across Wales.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-05ecf5
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/078979-2025
- Current Stage
- Award
- All Stages
- Award
Procurement Classification
- Notice Type
- UK6 - Contract Award Notice
- Procurement Type
- Standard
- Procurement Category
- Goods
- Procurement Method
- Direct
- Procurement Method Details
- Direct award
- Tender Suitability
- Not specified
- Awardee Scale
- Large
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33696500 - Laboratory reagents
Notice Value(s)
- Tender Value
- Not specified
- Lots Value
- Not specified
- Awards Value
- £355,550 £100K-£500K
- Contracts Value
- Not specified
Notice Dates
- Publication Date
- 2 Dec 20252 months ago
- Submission Deadline
- Not specified
- Future Notice Date
- Not specified
- Award Date
- 1 Dec 20252 months ago
- Contract Period
- 1 Jan 2026 - 31 Dec 2026 6-12 months
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Complete
- Awards Status
- Pending
- Contracts Status
- Not Specified
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- CARDIFF AND VALE UNIVERSITY HEALTH BOARD
- Additional Buyers
NHS WALES SHARED SERVICES PARTNERSHIP (HOSTED BY VELINDRE UNIVERSITY NHS TRUST)
- Contact Name
- Nicola Williams
- Contact Email
- corporate.services2@wales.nhs.uk, nicola.williams33@wales.nhs.com
- Contact Phone
- +442921500649
Buyer Location
- Locality
- CARDIFF
- Postcode
- CF14 4HH
- Post Town
- Cardiff
- Country
- Wales
-
- Major Region (ITL 1)
- TLL Wales
- Basic Region (ITL 2)
- TLL5 South East Wales
- Small Region (ITL 3)
- TLL51 Central Valleys and Bridgend
- Delivery Location
- Not specified
-
- Local Authority
- Rhondda Cynon Taf
- Electoral Ward
- Taff's Well
- Westminster Constituency
- Cardiff North
Further Information
Notice Documents
-
https://www.find-tender.service.gov.uk/Notice/078979-2025
2nd December 2025 - Contract award notice on Find a Tender -
https://www.find-tender.service.gov.uk/Notice/078933-2025
2nd December 2025 - Transparency notice on Find a Tender
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-05ecf5-2025-12-02T14:36:21Z",
"date": "2025-12-02T14:36:21Z",
"ocid": "ocds-h6vhtk-05ecf5",
"initiationType": "tender",
"parties": [
{
"id": "GB-PPON-PPPR-7969-BTJG",
"name": "Cardiff and Vale University Health Board",
"identifier": {
"scheme": "GB-PPON",
"id": "PPPR-7969-BTJG"
},
"address": {
"streetAddress": "Woodland House, Maes y Coed Road",
"locality": "Cardiff",
"postalCode": "CF14 4HH",
"country": "GB",
"countryName": "United Kingdom",
"region": "UKL22"
},
"contactPoint": {
"name": "Nicola Williams",
"email": "Nicola.williams33@wales.nhs.com",
"telephone": "+442921500649"
},
"roles": [
"buyer"
],
"details": {
"url": "http://nwssp.nhs.wales/ourservices/procurement-services/",
"classifications": [
{
"id": "publicAuthoritySubCentralGovernment",
"scheme": "UK_CA_TYPE",
"description": "Public authority - sub-central government"
},
{
"id": "GB-WLS",
"scheme": "UK_CA_DEVOLVED_REGULATIONS",
"description": "Welsh devolved regulations apply"
}
]
}
},
{
"id": "GB-PPON-PXWV-6492-CGMN",
"name": "NHS Wales Shared Services Partnership (hosted by Velindre University NHS Trust)",
"identifier": {
"scheme": "GB-PPON",
"id": "PXWV-6492-CGMN"
},
"address": {
"streetAddress": "4-5 Charnwood Court Heol Billingsley",
"locality": "Cardiff",
"postalCode": "CF15 7QZ",
"country": "GB",
"countryName": "United Kingdom",
"region": "UKL15"
},
"contactPoint": {
"email": "Corporate.Services2@wales.nhs.uk"
},
"roles": [
"procuringEntity"
],
"roleDetails": "The NHS Wales Shared Services Partnership (NWSSP) plays a vital role in supporting NHS Wales by delivering a wide range of professional, technical, and administrative services. It is hosted by Velindre University NHS Trust, which means Velindre provides the governance and infrastructure to support NWSSP's operations, but NWSSP itself serves all NHS organisations across Wales."
},
{
"id": "GB-PPON-PXNH-7642-BTWQ",
"name": "Invivoscribe technologies SARL",
"identifier": {
"scheme": "GB-PPON",
"id": "PXNH-7642-BTWQ"
},
"address": {
"streetAddress": "Zeppelinstrasse 1",
"locality": "Hallbergmoos",
"postalCode": "85399",
"country": "DE",
"countryName": "Germany",
"region": "DE"
},
"contactPoint": {
"email": "kkampe@invivoscribe.com"
},
"roles": [
"supplier"
],
"details": {
"url": "http://nwssp.nhs.wales/ourservices/procurement-services/",
"scale": "large",
"vcse": false,
"publicServiceMissionOrganization": false,
"shelteredWorkshop": false
}
}
],
"buyer": {
"id": "GB-PPON-PPPR-7969-BTJG",
"name": "Cardiff and Vale University Health Board"
},
"tender": {
"id": "CAV-DIR (25-26) 99",
"legalBasis": {
"id": "2023/54",
"scheme": "UKPGA",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
},
"title": "PROVISIONS OF PCR MASTER MIXES - CLONALITY TESTING",
"description": "The All Wales Medical Genomics Service (AWMGS) is awarding a direct contract for the supply of PCR mastermixes and associated reagents required for B and T cell clonality testing. These assays are critical for diagnosing and monitoring haematological malignancies such as lymphoma and must include validated clonal and polyclonal controls, as well as a control gene, to ensure accurate and reproducible results. In addition to product supply, the contract includes technical support to maintain continuity of service. Changing supplier would require extensive revalidation and re-accreditation of all assays, which would be a major undertaking and cause significant disruption to diagnostic services. This would lead to delays in patient testing, risking late or missed diagnoses and potentially endangering patient health and outcomes. The direct award is therefore essential to safeguard patient safety, maintain compliance with UKAS standards, and ensure uninterrupted delivery of critical genomic testing services across Wales",
"status": "complete",
"procurementMethod": "direct",
"procurementMethodDetails": "Direct award",
"procurementMethodRationale": "The All Wales Medical Genomics Service (AWMGS) requires PCR mastermixes and associated reagents for B and T cell clonality testing, which are critical for diagnosing and monitoring haematological malignancies such as lymphoma. These assays must include validated clonal and polyclonal controls and a control gene to ensure accurate and reproducible results. Changing supplier would necessitate full revalidation and re-accreditation of all existing assays under UKAS ISO 15189:2022 standards--a process that is highly complex, resource-intensive, and time-consuming. This would cause significant disruption to diagnostic services, resulting in delays to patient testing and reporting. Such delays pose a serious risk to patient safety, as timely diagnosis is essential for initiating treatment and improving clinical outcomes. Any interruption could lead to missed or late diagnoses, directly endangering patient health and potentially impacting survival rates. To avoid these unacceptable risks and maintain continuity of service, a direct award is the only viable option, service resilience, and safeguarding patient care across Wales.",
"lots": [
{
"id": "1",
"status": "complete"
}
],
"documents": [
{
"id": "conflictOfInterest",
"documentType": "conflictOfInterest",
"description": "Not published"
}
],
"riskDetails": "The main risks to contract performance include supply chain disruption, single supplier dependency, and potential delays in delivery or technical support. These risks could impact continuity of testing and patient care. Mitigation measures include strict service level agreements, proactive communication requirements, and performance monitoring through AWMGS's Quality Management System.",
"procurementMethodRationaleClassifications": [
{
"id": "singleSuppliersTechnicalReasons"
}
]
},
"awards": [
{
"id": "1",
"title": "PROVISIONS OF PCR MASTER MIXES - CLONALITY TESTING",
"status": "pending",
"value": {
"amountGross": 426660,
"amount": 355550,
"currency": "EUR"
},
"mainProcurementCategory": "goods",
"aboveThreshold": true,
"suppliers": [
{
"id": "GB-PPON-PXNH-7642-BTWQ",
"name": "Invivoscribe technologies SARL"
}
],
"items": [
{
"id": "1",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33696500",
"description": "Laboratory reagents"
}
],
"deliveryAddresses": [
{
"region": "UKL22",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKL22",
"country": "GB",
"countryName": "United Kingdom"
}
],
"relatedLot": "1"
}
],
"contractPeriod": {
"startDate": "2026-01-01T00:00:00+00:00",
"endDate": "2026-12-31T23:59:59+00:00"
},
"relatedLots": [
"1"
],
"documents": [
{
"id": "078933-2025",
"documentType": "awardNotice",
"noticeType": "UK5",
"description": "Transparency notice on Find a Tender",
"url": "https://www.find-tender.service.gov.uk/Notice/078933-2025",
"datePublished": "2025-12-02T13:45:33Z",
"format": "text/html"
},
{
"id": "078979-2025",
"documentType": "awardNotice",
"noticeType": "UK6",
"description": "Contract award notice on Find a Tender",
"url": "https://www.find-tender.service.gov.uk/Notice/078979-2025",
"datePublished": "2025-12-02T14:36:21Z",
"format": "text/html"
}
],
"milestones": [
{
"id": "1",
"type": "futureSignatureDate",
"dueDate": "2025-12-15T23:59:59+00:00",
"status": "scheduled"
}
],
"date": "2025-12-01T00:00:00+00:00",
"standstillPeriod": {
"endDate": "2025-12-11T23:59:59+00:00"
}
}
],
"language": "en"
}